Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
Product Monograph situation
-
We would like to get your thoughts on a potential situation and how it could affect marketing communication tools.
Product A: no existing indication, completely new to the market. Product B: Has an NOC for indication X.
Scenario: Single-use of Product A combined with ongoing or longer use of Product B is granted NOC for indication Z (i.e. PM for Product A) ahead of Product B receiving an additional indication for Z (PM for product B). Note that both products are undergoing Health Canada review for indication Z with the exact same data/ studies. The timing, however, may not be simultaneous.
Questions: (1) Can the logos of Product A and B be used on promotional pieces? (2) Can we callout the dosing of Product B explicitly? (3) Can information on Product A and B have equal prominence within pieces? (4) Given that product B already has an indication, an HCP and patient website already exists, can we send HCP/patients to Product B’s website (in a specific location) to get information on indication Z? (5) What are key considerations with respect to promotion?
Thank you.
-
We would like to get your thoughts on a potential situation and how it could affect marketing communication tools.
Product A: no existing indication, completely new to the market. Product B: Has an NOC for indication X.
Scenario: Single-use of Product A combined with ongoing or longer use of Product B is granted NOC for indication Z (i.e. PM for Product A) ahead of Product B receiving an additional indication for Z (PM for product B). Note that both products are undergoing Health Canada review for indication Z with the exact same data/ studies. The timing, however, may not be simultaneous.
Questions: (1) Can the logos of Product A and B be used on promotional pieces? (2) Can we callout the dosing of Product B explicitly? (3) Can information on Product A and B have equal prominence within pieces? (4) Given that product B already has an indication, an HCP and patient website already exists, can we send HCP/patients to Product B’s website (in a specific location) to get information on indication Z? (5) What are key considerations with respect to promotion?
Thank you.
Hi @lags
Thank you for your question. There are many factors that will affect the direction and use of both product logos in APS. This forum is not intended to address the specific and complex scenario that has been described. We suggest a consult meeting be arranged with PAAB to fully disclose the nature of the promotion and the content in the respective product monographs. We are unable to provide guidance without further information. Consult meetings may be arranged through our administrative team at review@paab.ca
